Clinical Trial Update: A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Colorectal Cancer Using ctDNA: Rapid 1 Trial [Phase 2]

View source ↗

Summary

A Phase II randomized trial evaluating ctDNA-guided therapeutic optimization in patients with refractory metastatic colorectal cancer has been terminated, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University of Florida | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-07-01